Clinical Trial Update: Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia [NA]

View source ↗

Summary

This completed clinical trial characterizes persistent pulmonary abnormalities following COVID-19 pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Viral Pneumonia

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Pneumonia, Viral | NA | Status: COMPLETED